Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an observational study that will be conducted on pregnant women under vaginal delivery or cesarean section. The magnesium sulfate will be given to appropriate participants with a protocol that obstetrician are already using in our hospital. After delivery, participants are asked to answer sequential questionnaires to assess postpartum depression.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Control group with participants who do not get magnesium sulfate administration. | ||
| Magnesium group | Intervention group with participants who get magnesium sulfate administration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Magnesium sulfate | Drug | Magnesium sulfate will be administered following a protocol that obstetricians already use in our hospital. |
|
| Measure | Description | Time Frame |
|---|---|---|
| postpartum depression | depression diagnosis using K-EPDS(Korean version of Edinburgh Postnatal Depression Scale) on a scale of 7 to 30 points. | 6 week after discharge |
| postpartum depression severity | depression severity using K-EPDS; mild (7~13 points), moderate (14~19 points), severe (20~30 points) | 6 week after discharge |
| Measure | Description | Time Frame |
|---|---|---|
| postpartum depression | depression diagnosis using K-EPDS(Korean version of Edinburgh Postnatal Depression Scale) on a scale of 7 to 30 points. | 2week after discharge |
| postpartum depression severity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Participants are all pregnant women.
Not provided
This is aimed adult singleton pregnant women with gestation age more than 30 weeks who are scheduled to give birth. Participants who get peripartum administration of magnesium sulfate are classified as magnesium group, and participants who do not get magnesium sulfate administration are classified as control group.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Su Yeon Kim, Dr. | Contact | +82-10-3325-2690 | kittyrockz@nate.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Recruiting | Seongnam-si | Gyeonguido | 13620 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019052 | Depression, Postpartum |
| ID | Term |
|---|---|
| D011644 | Puerperal Disorders |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008278 | Magnesium Sulfate |
| ID | Term |
|---|---|
| D017616 | Magnesium Compounds |
| D007287 | Inorganic Chemicals |
| D013431 | Sulfates |
| D013464 | Sulfuric Acids |
Not provided
Not provided
Not provided
Not provided
Not provided
depression severity using K-EPDS; mild (7~13 points), moderate (14~19 points), severe (20~30 points)
| 2 week after discharge |
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
| D013456 |
| Sulfur Acids |
| D013457 | Sulfur Compounds |